Metastases: Difference between revisions

Jump to navigation Jump to search
Michael (talk | contribs)
Michael (talk | contribs)
m →Pending: fix typo
Line 68: Line 68:
NEGATIVE: CK20, TTF-1, CDX2, HER2, GCDFP.
NEGATIVE: CK20, TTF-1, CDX2, HER2, GCDFP.


The immunostaining prolife is compatible with a metastatic breast carcinoma.
The immunostaining profile is compatible with a metastatic breast carcinoma.


ER, PR and HER2 are interpreted as Class I IHC tests (results used by pathologists),
ER, PR and HER2 are interpreted as Class I IHC tests (results used by pathologists),